Search

Your search keyword '"Griffiths, Michael John"' showing total 10 results
Start Over Author "Griffiths, Michael John"
10 results on '"Griffiths, Michael John"'

1. Neurological and Psychiatric Manifestations of COVID-19 in UK Children: A Prospective National Cohort Study

Author

Ray, Stephen T.J., primary, Abdel-Mannan, Omar, additional, Sa, Mario, additional, Fuller, Charlotte, additional, Wood, Greta K., additional, Psyden, Karen, additional, Yoong, Michael, additional, Ramas, S., additional, McCullagh, Helen, additional, Scott, D., additional, McMahon, M., additional, Thomas, Naomi, additional, Taylor, M., additional, Vollmer, Brigitte, additional, Illingworth, Marjorie, additional, McCrea, Nadine, additional, Davies, Victoria, additional, Whitehouse, William, additional, Zuberi, S., additional, Guthrie, Keira, additional, Wassmer, Evangeline, additional, Shah, N., additional, Baker, Mark R., additional, Tiwary, Sangeeta, additional, Petropoulos, Christina, additional, Vlachou, Victoria, additional, Kinali, Maria, additional, Tan, H. Jeen, additional, Varma, Uma, additional, Ram, Dipak, additional, Avula, Shivaram, additional, Breen, Gerome, additional, Enright, Noelle, additional, Hassell, Jane, additional, Ross Russell, Amy L., additional, Kumar, R., additional, Mulholland, Rachel E., additional, Pett, Sarah, additional, Galea, Ian, additional, Thomas, Rhys H., additional, Lim, Ming, additional, Hacohen, Yael, additional, Solomon, T., additional, Griffiths, Michael John, additional, Michael, B.D., additional, Kneen, Rachel, additional, and Group, CoroNerve Studies, additional

Published
2021
Full Text
View/download PDF

8. Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal

Author

Rayamajhi, Ajit, primary, Nightingale, Sam, additional, Bhatta, Nisha Keshary, additional, Singh, Rupa, additional, Ledger, Elizabeth, additional, Bista, Krishna Prasad, additional, Lewthwaite, Penny, additional, Mahaseth, Chandeshwar, additional, Turtle, Lance, additional, Robinson, Jaimie Sue, additional, Galbraith, Sareen Elizabeth, additional, Wnek, Malgorzata, additional, Johnson, Barbara Wilmot, additional, Faragher, Brian, additional, Kneen, Rachel, additional, Griffiths, Michael John, additional, and Solomon, Tom, additional

Published
2015
Full Text
View/download PDF

9. A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal

Author

Rayamajhi, Ajit, primary, Nightingale, Sam, additional, Bhatta, Nisha Keshary, additional, Singh, Rupa, additional, Ledger, Elizabeth, additional, Bista, Krishna Prasad, additional, Lewthwaite, Penny, additional, Mahaseth, Chandeshwar, additional, Turtle, Lance, additional, Robinson, Jaimie Sue, additional, Galbraith, Sareen Elizabeth, additional, Wnek, Malgorzata, additional, Johnson, Barbara Wilmot, additional, Faragher, Brian, additional, Griffiths, Michael John, additional, and Solomon, Tom, additional

Published
2015
Full Text
View/download PDF

10. A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease.

Author

Walker, Lauren Elizabeth, Griffiths, Michael John, McGill, Fiona, Lewthwaite, Penelope, Sills, Graeme John, Jorgensen, Andrea, Antoine, Daniel James, Solomon, Tom, Marson, Anthony Guy, and Pirmohamed, Munir

Subjects
*CEREBROSPINAL fluid, *NERVOUS system, *SERUM, *BODY fluids, *ORGANS (Anatomy)
Abstract

Aims:To determine whether a correlation exists between paired cerebrospinal fluid (CSF) and serum levels of a novel inflammatory biomarker, high-mobility group box 1 (HMGB1), in different neurological conditions. Methods:HMGB1 was measured in the serum and CSF of 46 neurological patients (18 idiopathic intracranial hypertension [IIH], 18 neurological infection/inflammation [NII] and 10 Rasmussen’s encephalitis [RE]). Results:Mean serum (± SD) HMGB1 levels were 1.43 ± 0.54, 25.28 ± 27.9 and 1.89 ± 1.49 ng/ml for the patients with IIH, NII and RE, respectively. Corresponding mean (± SD) CSF levels were 0.35 ± 0.22, 4.48 ± 6.56 and 2.24 ± 2.35 ng/ml. Both CSF and serum HMGB1 was elevated in NII. Elevated CSF HMGB1 was demonstrated in RE. There was no direct correlation between CSF and serum levels of HMGB1. Conclusion:Serum HMGB1 cannot be used as a surrogate measure for CSF levels. CSF HMGB1 was elevated in NII and RE, its role as a prognostic/stratification biomarker needs further study. [ABSTRACT FROM PUBLISHER]

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results